Literature DB >> 31649041

Prevalence of human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer in imprisoned women worldwide: a systematic review and meta-analysis.

Nadia Escobar1, Emma Plugge2.   

Abstract

BACKGROUND AND OBJECTIVES: Imprisoned women have higher rates of abnormalities at cervical screening and some studies suggest that cervical cancer is the most common cancer in this population. The aim of this work was to summarise the current evidence on the prevalence of human papilloma virus (HPV) infection, cervical cancer and precancerous lesions in women in prison worldwide and to compare these rates with the general population.
METHODS: We systematically searched and reviewed published and unpublished data reporting the prevalence of any HPV infection, cervical intraepithelial neoplasia (CIN) and cervical cancer in imprisoned women. We created forest plots with prevalence estimates from studies with comparable outcomes and of prevalence ratios using data from national screening programmes as a comparison group.
FINDINGS: A total of 53 533 imprisoned women from 10 countries and 35 studies were included in the review. The prevalence of HPV among prisoners ranged from 10.5% to 55.4% with significant heterogeneity. The prevalence of CIN diagnosed by cytology in prisoners ranged from 0% to 22%. Ratios comparing the prevalence of CIN in imprisoned women to that in the community ranged from 1.13 to 5.46. Cancer prevalence estimates were at least 100 times higher than in populations participating in national screening programmes.
CONCLUSION: Imprisoned women are at higher risk of cervical cancer than the general population. There is a high prevalence of HPV infection and precancerous lesions in this population. Targeted programmes for control of risk factors and the development of more effective cervical screening programmes are recommended. PROSPERO REGISTRATION NUMBER: CRD42014009690. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer epidemiology; cancer: cervix; health inequalities; prevention; public health

Mesh:

Year:  2019        PMID: 31649041     DOI: 10.1136/jech-2019-212557

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania.

Authors:  Alin Popescu; Marius Craina; Stelian Pantea; Catalin Pirvu; Veronica Daniela Chiriac; Iosif Marincu; Felix Bratosin; Iulia Bogdan; Samer Hosin; Cosmin Citu; Elena Bernad; Radu Neamtu; Catalin Dumitru; Adelina Geanina Mocanu; Claudiu Avram; Adrian Gluhovschi
Journal:  Diagnostics (Basel)       Date:  2022-04-06

2.  Quantifying the under-reporting of uncorrelated longitudal data: the genital warts example.

Authors:  David Moriña; Amanda Fernández-Fontelo; Alejandra Cabaña; Pedro Puig; Laura Monfil; Maria Brotons; Mireia Diaz
Journal:  BMC Med Res Methodol       Date:  2021-01-06       Impact factor: 4.615

3.  p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection.

Authors:  Hirotaka Ishida; Atsuko Kasajima; Fumiyoshi Fujishima; Ryujiro Akaishi; Shunsuke Ueki; Yuto Yamazaki; Yoshiaki Onodera; Xin Gao; Hiroshi Okamoto; Yusuke Taniyama; Takashi Kamei; Hironobu Sasano
Journal:  Virchows Arch       Date:  2020-06-16       Impact factor: 4.064

4.  Knockdown of lncRNA NEAT1 suppresses proliferation and migration, and induces apoptosis of cervical cancer cells by regulating the miR‑377/FGFR1 axis.

Authors:  Feng Geng; Wen-Cong Jia; Tao Li; Na Li; Wei Wei
Journal:  Mol Med Rep       Date:  2021-11-15       Impact factor: 2.952

Review 5.  The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity.

Authors:  Ya Wang; Xiaoli Wang; Meiling Zhu; Li Ge; Xiaochen Liu; Kaikai Su; Zhengzheng Chen; Weidong Zhao
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

6.  Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review.

Authors:  Mina Galeshi; Hoda Shirafkan; Shahla Yazdani; Zahra Motaghi
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

7.  HPV Vaccination and Cervical Cancer Screening: Assessing Awareness, Attitudes, and Adherence in Detained Women.

Authors:  Gabriella Di Giuseppe; Lucio Folcarelli; Raffaele Lanzano; Francesco Napolitano; Maria Pavia
Journal:  Vaccines (Basel)       Date:  2022-08-08

8.  Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana.

Authors:  Lawrence Kofi Acheampong; Kofi Effah; Joseph Emmanuel Amuah; Ethel Tekpor; Comfort Mawusi Wormenor; Isaac Gedzah; Seyram Kemawor; Ateba Cynthia Kachana; Peace Afi Danso; Nana Owusu Mensah Essel; Mabel Asomaning; Dominic Agyiri; Patrick Kafui Akakpo
Journal:  Ecancermedicalscience       Date:  2021-06-14

9.  Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial.

Authors:  Dolorès Pourette; Amber Cripps; Margaux Guerrien; Caroline Desprès; Eric Opigez; Marc Bardou; Alexandre Dumont
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.